DEC 27, 2016 7:41 PM PST

Super-Enhancers Implicated in Autoimmune Disease

WRITTEN BY: Kara Marker

Regulatory T cells (Tregs) step in to mute the immune system after it has mounted a response against whatever foreign invader is tormenting the body. An immune attack is necessary to keep the body protected from invaders, but at a certain point Tregs ensure that the immune system does not go overboard and hurt healthy human cells, causing autoimmune disease.

Source: EpiBeat

The current study from the Immunology Frontier Research Center (IFReC) at Osaka University in Japan thusly focused on the origin of Tregs, of the precursor cells that are destined to become the specialized T cells that prevent autoimmune reactions.

They found that Treg development, which occurs in the thymus, is controlled by the establishment of super-enhancers, regulators of gene expression that appear to also be involved in Treg development.  “Super-enhancers appeared to be a pre-requisite for Treg cell development, so we sought molecules controlling super-enhancers,” explained IFReC professor Shimon Sakaguchi.

They found that the molecular mechanism behind Treg malfunction, which causes autoimmune diseases, was a protein called Satb1, which the observed as a regulator of the super-enhancers essential for Treg cell development.

Satb1 levels are inherently highest just before Tregs develop, and there is a sudden reduction right after they eventually develop. This connection is due to the bond between Satb1 and the super-enhancers responsible for Treg development, researchers found, but Satb1 is not bound to the Tregs themselves.

“Satb1 appears to be necessary for the differentiation of Treg cells but not for the maintenance of Treg cells,” explained first author Dr. Yohko Kitagawa.

During their study, mutant mice lacking Satb1 showed impaired Treg development and signs of autoimmune disease. Additionally, Treg progenitor cells exhibited inferior super enhancer activity, leading to a reduction in expression of vital genes for Treg development.

Ultimately, Sakaguchi, Kitagawa, and the rest of the research team concluded that a lack of ample Satb1-dependent super-enhancers could be causing autoimmune diseases and allergies in some people, a result that leaves room for future research into Satb1 as a target for treating these conditions.

The current study was recently published in the journal Nature Immunology.

Sources: Osaka University, Immunology Frontier Research CenterNature Genetics

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 29, 2020
Cell & Molecular Biology
MAR 29, 2020
Learning More About Boosting Immunity in Older Adults
Older adults are more susceptible to infections and don't generate a robust immune response after a vaccination.
APR 01, 2020
Immunology
APR 01, 2020
New Airway-Hugging Immune Cells Discovered in the Lung
  Scientists have discovered a previously unknown subset of immune cells residing in the lung that specifically com ...
APR 07, 2020
Immunology
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
APR 07, 2020
Microbiology
APR 07, 2020
Second COVID-19 Vaccine Enters Human Trials
Yesterday, Inovio Pharmaceuticals, Inc. announced that it will begin human trials on a potential vaccine for COVID-19.
MAY 17, 2020
Coronavirus
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
JUN 15, 2020
Immunology
JUN 15, 2020
Experimental MS Treatment Relies on "Retraining" the Immune System
When the immune system goes awry and fails to regulate itself, immune cells may attack the body’s own tissues. Sci ...
Loading Comments...